Relationship between blood metals and inflammation in taxi drivers
Carregando...
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2015
Editora
ELSEVIER SCIENCE BV
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
BRUCKER, Natalia
MORO, Angela
CHARAO, Mariele
BUBOLS, Guilherme
NASCIMENTO, Sabrina
GOETHEL, Gabriela
BARTH, Anelise
PROHMANN, Ana C.
ROCHA, Rafael
MORESCO, Rafael
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICA CHIMICA ACTA, v.444, p.176-181, 2015
Resumo
Background: Cardiovascular disease is a cause of concern in public health worldwide, reinforcing the need for studies related to the identification of potential agents that contribute to the inflammation process and atherosclerosis. This study aimed to evaluate whether metals are associated with inflammatory and kidney damage and could contribute to the atherosclerosis process. Methods: Blood metals, inflammatory markers, homocysteine, antioxidants and renal markers were measured in 42 taxi drivers and 27 controls (non-occupationally exposed). Results: Taxi drivers had increased Hg, As, Pb and Cd levels, however Cu and Zn levels were decreased compared to controls (p < 0.05). Hg, As and Pb levels were positively associated with pro-inflammatory cytokines, nitric oxide and negatively associated with glutathione peroxidase. Moreover, Hg, As and Pb presented positive associations with homocysteine, an independent risk factor for atherosclerosis. Regarding markers of kidney function, N-acetyl-beta-D-glucosaminidase levels were increased in taxi drivers and correlated to inflammation markers. Conclusion: Hg levels were found above the recommended limits in taxi drivers and both Hg and As levels showed associations with inflammatory process, oxidative status and homocysteine. Thus, chemical substances as Hg and As can be considered as additional contributors to the development of cardiovascular diseases.
Palavras-chave
Toxic metals, Inflammation markers, Homocysteine, Occupational exposure
Referências
- Al Bakheet SA, 2013, ENVIRON POLLUT, V181, P226, DOI 10.1016/j.envpol.2013.06.014
- Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836
- Bellinger DC, 2008, BASIC CLIN PHARMACOL, V102, P237, DOI 10.1111/j.1742-7843.2007.00164.x
- Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9
- Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf
- Burgaz S, 2002, CHEMOSPHERE, V47, P57, DOI 10.1016/S0045-6535(01)00185-0
- Burtis CA, 2008, TEITZ FUNDAMENTOS CL, V6th
- Charao MF, 2012, J BRAZIL CHEM SOC, V23, P1441, DOI 10.1590/S0103-50532012005000001
- Ciarrocca M, 2013, CHEMOSPHERE, V90, P2077, DOI 10.1016/j.chemosphere.2012.10.060
- Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73
- de Miranda RM, 2012, AIR QUAL ATMOS HLTH, V5, P63, DOI 10.1007/s11869-010-0124-1
- Delfino RJ, 2011, AIR QUAL ATMOS HLTH, V4, P37, DOI 10.1007/s11869-010-0095-2
- Grass DS, 2010, ENVIRON RES, V110, P1, DOI 10.1016/j.envres.2009.10.006
- Hambach R, 2013, TOXICOL LETT, V222, P233, DOI 10.1016/j.toxlet.2013.06.218
- Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009
- Hennig B, 2012, ENVIRON HEALTH PERSP, V120, P771, DOI 10.1289/ehp.1104712
- Hennig B, 2007, NUTR METAB CARDIOVAS, V17, P162, DOI 10.1016/j.numecd.2006.01.003
- Huang HB, 2013, CANCER EPIDEM BIOMAR, V22, P102, DOI 10.1158/1055-9965.EPI-12-0706
- Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032
- Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012
- Kelly FJ, 2004, P NUTR SOC, V63, P579, DOI 10.1079/PNS2004388
- Knibbs LD, 2012, ENVIRON INT, V49, P110, DOI 10.1016/j.envint.2012.08.013
- Kordas K, 2010, SCI TOTAL ENVIRON, V408, P4488, DOI 10.1016/j.scitotenv.2010.06.041
- Kuno R, 2013, INT J HYG ENVIR HEAL, V216, P243, DOI 10.1016/j.ijheh.2012.05.010
- Lai CH, 2005, OCCUP ENVIRON MED, V62, P216, DOI 10.1136/oem.2004.015107
- Li HM, 2013, SCI TOTAL ENVIRON, V456, P212, DOI 10.1016/j.scitotenv.2013.03.094
- MARUHN D, 1976, CLIN CHIM ACTA, V73, P453, DOI 10.1016/0009-8981(76)90147-9
- Mateus VL, 2013, SPECTROCHIM ACTA B, V86, P5
- Mortada WI, 2001, AM J NEPHROL, V21, P274, DOI 10.1159/000046261
- Motts JA, 2014, ENVIRON RES, V132, P12, DOI 10.1016/j.envres.2014.03.024
- Nascimento SN, 2015, ENVIRON RES, V136, P387
- Ojo JO, 2014, ENVIRON SCI POLLUT R, V21, P1124, DOI 10.1007/s11356-013-1951-z
- Olsen L, 2012, INT J HYG ENVIR HEAL, V215, P411, DOI 10.1016/j.ijheh.2011.11.004
- PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
- Rambouskova J, 2013, ARCH GERONTOL GERIAT, V56, P389, DOI 10.1016/j.archger.2012.11.002
- Reyes JL, 2013, BIOMED RES INT, DOI 10.1155/2013/730789
- Schulte PA, 2012, TOXICOL LETT, V213, P91, DOI 10.1016/j.toxlet.2011.03.027
- Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3
- Silbergeld Ellen K, 2005, Toxicol Appl Pharmacol, V207, P282, DOI 10.1016/j.taap.2004.11.035
- Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332
- Tatsch E, 2011, CLIN BIOCHEM, V44, P348, DOI 10.1016/j.clinbiochem.2010.12.011
- Tchounwou PB, 2004, MOL CELL BIOCHEM, V255, P47, DOI 10.1023/B:MCBI.0000007260.32981.b9
- Thron RW, 1996, OTOLARYNG HEAD NECK, V114, P281, DOI 10.1016/S0194-5998(96)70184-5
- Traversi D, 2010, J ENVIRON MONITOR, V12, P484, DOI 10.1039/b913314c
- Valavanidis A, 2005, REDOX REP, V10, P37, DOI 10.1179/135100005X21606
- Vestra MD, 2005, J AM SOC NEPHROL S1, V16, pS78, DOI 10.1681/ASN.2004110961
- Wang GS, 2008, TOXICOL APPL PHARM, V233, P92, DOI 10.1016/j.taap.2008.01.017
- WHO, 1996, TRAC EL HUM NUTR HLT
- Wu MM, 2003, ENVIRON HEALTH PERSP, V111, P1429, DOI 10.1289/txg.6396